Retavase (reteplase), a thrombolytic to restore blood flow after an acute MI
Boehringer Mannheim just started marketing Retavase (reteplase), a thrombolytic to restore blood flow after an acute MI.
Retavase is a derivative of tissue plasminogen activator (tPA).
It restores blood flow within 90 minutes in more patients than tPA (Activase, alteplase).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote